Blue Water Life Science Advisors, L.P. 13F annual report

Blue Water Life Science Advisors, L.P. is an investment fund managing more than $103 billion ran by Nate Cornell. There are currently 8 companies in Mrs. Cornell’s portfolio. The largest investments include Natera Inc and Guardant Health Inc, together worth $71 billion.

$103 billion Assets Under Management (AUM)

As of 2nd August 2024, Blue Water Life Science Advisors, L.P.’s top holding is 503,094 shares of Natera Inc currently worth over $54.5 billion and making up 53.0% of the portfolio value. Relative to the number of outstanding shares of Natera Inc, Blue Water Life Science Advisors, L.P. owns more than approximately 0.1% of the company. In addition, the fund holds 571,047 shares of Guardant Health Inc worth $16.5 billion, whose value grew 33.9% in the past six months. The third-largest holding is Akoya Biosciences Inc worth $11 billion and the next is Caredx Inc worth $7.92 billion, with 510,000 shares owned.

Currently, Blue Water Life Science Advisors, L.P.'s portfolio is worth at least $103 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Blue Water Life Science Advisors, L.P.

The Blue Water Life Science Advisors, L.P. office and employees reside in Larkspur, California. According to the last 13-F report filed with the SEC, Nate Cornell serves as the Founder, CIO & CCO at Blue Water Life Science Advisors, L.P..

Recent trades

In the most recent 13F filing, Blue Water Life Science Advisors, L.P. revealed that it had opened a new position in Caredx Inc and bought 510,000 shares worth $7.92 billion. This means they effectively own approximately 0.1% of the company. Caredx Inc makes up 8.9% of the fund's Health Care sector allocation and has grown its share price by 179.5% in the past year.

The investment fund also strengthened its position in 10x Genomics by buying 35,500 additional shares. This makes their stake in 10x Genomics total 230,000 shares worth $4.47 billion. 10x Genomics dropped 64.4% in the past year.

On the other hand, there are companies that Blue Water Life Science Advisors, L.P. is getting rid of from its portfolio. Blue Water Life Science Advisors, L.P. closed its position in Adaptive Biotechnologies Cor on 9th August 2024. It sold the previously owned 1,687,665 shares for $5.42 billion. Nate Cornell also disclosed a decreased stake in Quanterix Corp by approximately 0.1%. This leaves the value of the investment at $3.68 billion and 278,393 shares.

One of the smallest hedge funds

The two most similar investment funds to Blue Water Life Science Advisors, L.P. are Wick Capital Partners and Cowbird Capital L.P.. They manage $103 billion and $103 billion respectively.

Nate Cornell investment strategy

Blue Water Life Science Advisors, L.P.’s portfolio is diversified across 2 sectors. Currently, their heaviest sector is Health Care — making up 87.0% of the total portfolio value. The fund focuses on investments in the United States as 75.0% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up approximately 0.1% of the total holdings value. On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio. The average market cap of the portfolio companies is close to $3.76 billion.

The complete list of Blue Water Life Science Advisors, L.P. trades based on 13F SEC filings

These positions were updated on August 9th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security	Shares Owned	Value	Allocation
Natera Inc	No change 503,094	$54,480,049,000	52.98%
Guardant Health Inc	No change 571,047	$16,491,837,000	16.04%
Akoya Biosciences Inc	No change 4,697,785	$10,992,817,000	10.69%
Caredx Inc	Opened 510,000	$7,920,300,000	7.70%
Adaptive Biotechnologies Cor	Closed 1,687,665	$5,417,405,000
10x Genomics, Inc.	18.25% 230,000	$4,473,500,000	4.35%
Quanterix Corp	9.93% 278,393	$3,677,572,000	3.58%
Exact Sciences Corp.	No change 57,343	$2,422,742,000	2.36%
Maxcyte Inc	No change 603,937	$2,367,433,000	2.30%
No transactions found
Showing first 500 out of 9 holdings